This page is best viewed using frames. You should upgrade your browser to see the page as it is intended. In the meantime, you can begin your navigation here. ...

We offer computer simulation support in drug development, based on the affinity and pharmacology of a new drug towards human receptors for Alzheimer's disease, schizophrenia and Parkinson's disease. Preclinical Discovery Validating the impact of targets in the combined neuronal circuit outcome Candi...

Sitemap Home Page Mission Statement Further Information Services Technology Limitation of Animal Models Publications News About Us Contact Last updated January 24, 2012. ...

Despite tremendous progress in basic science, there have been no new breakthroughs in the treatment of many CNS diseases. CNS quantitative systems pharmacology is based on the realization that human pathology is driven by a network imbalance rather than deficits at a single target or gene. Computer-...

Contact In Silico Biosciences, Inc. 405 Waltham Street Lexington, MA02421 USA Hugo Geerts: 267-679-8090 e-mail: info2@in-silico-biosciences.com ...